NCT06710717View on ClinicalTrials.gov

Autologous CD19 Car T-Cell Therapy For Severe Refractory Systemic Lupus Erythematosus (SLE)

PHASE1RecruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 3, 2025

Primary Completion Date

December 2, 2028

Study Completion Date

January 2, 2029

Conditions
Systemic Lupus Erythematous (SLE)
Interventions
BIOLOGICAL

CD19 CAR-T cells

Study participant will be given single infusion of autologous CD19 CAR-T cells following lymphodepletion chemotherapy

Trial Locations (1)

56000

RECRUITING

University Kebangsaan Malaysia Medical Center, Bandar Tun Razak

All Listed Sponsors
collaborator

Plutonet Sdn Bhd

UNKNOWN

lead

National University of Malaysia

OTHER